Sensus Healthcare, Inc.SRTSNASDAQ
Loading
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +3.98% | -21.75% | -20.82% | -22.12% | -62.20% |
| Gross Profit Growth | -9.23% | -34.64% | -46.47% | -48.23% | -73.29% |
| EBITDA Growth | -68.53% | -183.23% | -186.65% | -61.05% | -263.76% |
| Operating Income Growth | -69.05% | -191.65% | -198.03% | -271.84% | -282.44% |
| Net Income Growth | -63.28% | -213.10% | -164.33% | -177.61% | -304.85% |
| EPS Growth | -63.62% | -214.29% | -164.21% | -177.69% | -300.85% |
| EPS Diluted Growth | -63.85% | -214.29% | -164.34% | -177.79% | -302.13% |
| Weighted Average Shares Growth | +0.39% | +0.11% | +0.13% | +0.04% | -0.05% |
| Weighted Average Shares Diluted Growth | +1.04% | +0.25% | -0.08% | -0.11% | -0.70% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | -131.00% | +0.00% | -26.31% | -41.94% | +0.00% |
| Free Cash Flow Growth | -119.87% | +0.00% | -26.90% | -36.64% | +0.00% |
| Receivables Growth | +85.35% | -8.19% | -31.00% | -44.96% | -69.38% |
| Inventory Growth | +13.35% | -32.59% | -2.85% | +20.16% | +8.32% |
| Asset Growth | +15.74% | +5.13% | +1.18% | -2.61% | -14.68% |
| Book Value per Share Growth | +13.86% | +3.46% | -1.71% | -5.46% | -13.80% |
| Debt Growth | -23.12% | -12.10% | -14.76% | -17.97% | +12.96% |
| R&D Expense Growth | +130.24% | +181.43% | +69.86% | +110.78% | +20.56% |
| SG&A Expenses Growth | +142.63% | +54.23% | +31.07% | +20.16% | -17.12% |